Semustine is a drug used in chemotherapy. It is structurally similar to lomustine, being distinguished from it only by an additional methyl group. It has been taken off the drug market for investigation of its cancerous effects, rated as IARC Group 1 carcinogen or a known carcinogen. References: Kobiakov GL. [Clinical significance of mustoforan in management of malignant glioma]. Vopr Onkol. 2007;53(6):724-9. Review. Russian. PubMed PMID: 18416147.

纯度：≥98%

CAS：13909-09-6